Jnana Therapeutics

Company developing a drug discovery platform for targeting the solute carrier (SLC) family of transporters

placeBoston, Massachusetts, United States calendar_todayFounded 2017 groups10 employees language jnanatx.com

Registered entities

Innovation

21 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 332 times.

YearFilings
20203
20214
20224
20235
20249
202515
20265

Social engagement

Social engagement: 12.8K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Polaris Partners, Avalon Ventures, RA Capital Management, Bain Capital Life Sciences.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

29 Oct 2025 · Director, Bioinformatics · Boston

Based on job postings tracked across public sources.

Recent activity

12 Sep 2025
Event
MedChem Campus 2025
Coming soon